Comparison of [¹⁸F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation

References

• Abe Y, Matsuzawa T, Fujiwara T, Fukuda H, Itoh M, Yamada K, Yamaguchi K, Sato T, Ido T. Assessment of radiotherapeutic effects on experimental tumours using 18F-2-fluoro-2-deoxy-D-glucose. European Journal of Nuclear Medicine 1986; 12: 325–328
   PubMedGoogle Scholar
• Abe Y, Matsuzawa T, Fujiwara T, Itoh M, Fukuda H, Yamaguchi K, Kubota K, Hatazawa J, Tada M, Ido T, et al. Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: Preliminary study of lung cancer. International Journal of Radiation Oncology, Biology, Physics 1990; 19: 1005–1010
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nature Reviews Cancer 2008; 8: 545–554
   PubMed Web of Science ®Google Scholar
• Bentzen L, Keiding S, Horsman M, Falborg L, Hansen S, Overgaard J. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography – a study evaluating [18F]Fluoro-2-deoxy-D-glucose. Acta Oncologica 2000; 39: 629–637
   PubMed Web of Science ®Google Scholar
• Beuthien-Baumann B, Gabrys D, Wüllrich K, Hofheinz F, Krause M, Bergmann R, Hessel F, Yaromina A, Eicheler W, Baumann M. Impact of tumour hypoxia on the FDG uptake in two human tumour models on nude mice investigated with PET, autoradiography and functional histology. Radiotherapy and Oncology 2006; 81: S142
   Web of Science ®Google Scholar
• Brown R, Fisher S, Wahl R. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. Journal of Nuclear Medicine 1993; 34: 75–82
   PubMed Web of Science ®Google Scholar
• Clavo A, Brown R, Wahl R. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. Journal of Nuclear Medicine 1995; 36: 1625–1632
   PubMed Web of Science ®Google Scholar
• Dearling J, Flynn A, Sutcliffe-Goulden J, Petrie I, Boden R, Green A, Boxer G, Begent R, Pedley R. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. Journal of Nuclear Medicine 2004; 45: 101–107
   PubMed Web of Science ®Google Scholar
• De Wit M, Raabe A, Seegers B, Buchert R, Beck-Bornholdt H-P, Alberti W, Hossfeld D. Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose. International Journal of Radiation Biology 2004; 80: 529–539
   PubMed Web of Science ®Google Scholar
• Dierckx R, Van De Wiele C. FDG uptake, a surrogate of tumour hypoxia?. European Journal of Nuclear Medicine and Molecular Imaging 2008; 35: 1544–1549
   PubMed Web of Science ®Google Scholar
• Füchtner F, Steinbach J, Mäding P, Johannsen B. Basic hydrolysis of 2-[18F]Fluoro-1,3,4,6-tetra-O-acetyl-D-glucose in the preparation of 2-[18F]Fluoro-2-deoxy-D-glucose. Applied Radiation and Isotopes 1996; 47: 61–66
   Web of Science ®Google Scholar
• Gillies R, Robey I, Gatenby R. Causes and consequences of increased glucose metabolism of cancers. Journal of Nuclear Medicine 2008; 49(Suppl. 2)24–42
   Google Scholar
• Gray L, Conger A, Ebert M, Hornsey S, Scott O. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. The British Journal of Radiology 1953; 26: 638–648
   PubMed Web of Science ®Google Scholar
• Hautzel H, Muller-Gartner H. Early changes in fluorine-18-FDG uptake during radiotherapy. Journal of Nuclear Medicine 1997; 38: 1384–1386
   PubMed Web of Science ®Google Scholar
• Hoskin P, Sibtain A, Daley F, Saunders M, Wilson G. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiotherapy and Oncology 2004; 72: 159–168
   PubMed Web of Science ®Google Scholar
• Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. Journal of Nuclear Medicine 1991; 32: 1655–1660
   PubMed Web of Science ®Google Scholar
• Keyes J. SUV: Standard uptake or silly useless value?. Journal of Nuclear Medicine 1995; 36: 1836–1839
   PubMed Web of Science ®Google Scholar
• Koritzinsky M, Wouters B, Amellem O, Pettersen E. Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation. International Journal of Radiation Biology 2001; 77: 319–328
   PubMed Web of Science ®Google Scholar
• Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: A microautoradiographic study. Journal of Nuclear Medicine 1994; 35: 1067–1075
   PubMed Web of Science ®Google Scholar
• Macheda M, Rogers S, Best J. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. Journal of Cellular Physiology 2005; 202: 654–662
   PubMed Web of Science ®Google Scholar
• Plathow C, Weber W. Tumor cell metabolism imaging. Journal of Nuclear Medicine 2008; 49(Suppl. 2)43–63
   Google Scholar
• Pugachev A, Ruan S, Carlin S, Larson S, Campa J, Ling C, Humm J. Dependence of FDG uptake on tumor microenvironment. International Journal of Radiation Oncology, Biology, Physics 2005; 62: 545–553
   PubMed Web of Science ®Google Scholar
• Rege S, Safa A, Chaiken L, Hoh C, Juillard G, Withers H. Positron emission tomography: An independent indicator of radiocurability in head and neck carcinomas. American Journal of Clinical Oncology 2000; 23: 164–169
   PubMed Web of Science ®Google Scholar
• Reske S, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, ‘Onko-PET III’, 21 July and 19 September 2000. European Journal of Nuclear Medicine 2001; 28: 1707–1723
   PubMedGoogle Scholar
• Schreiber A, Krause M, Zips D, Dorfler A, Richter K, Vettermann S, Petersen C, Beuthien-Baumann B, Thummler D, Baumann M. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation. Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics 2004; 180: 375–382
   PubMed Web of Science ®Google Scholar
• Schuetze C, Bergmann R, Mosch B, Yaromina A, Hessel F, Krause M, Thames H, Zips D, Maeding P, Baumann M, Beuthien-Baumann B. Pre-treatment FMISO hypoxic volume is a significant prognostic factor for local control after irradiation of FaDu HNSCC xenografts. Radiotherapy and Oncology 2008; 88: S102
   PubMed Web of Science ®Google Scholar
• Schuetze C, Bergmann R, Yaromina A, Hessel F, Kotzerke J, Steinbach J, Baumann M, Beuthien-Baumann B. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiotherapy and Oncology 2007; 83: 311–315
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Sakahara H, Sato K, Harada N, Fukumoto D, Kakiuchi T, Hirano T, Kohno E, Tsukada H. Evaluation of 3′-deoxy-3′-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice. Journal of Nuclear Medicine 2004; 45: 1754–1758
   PubMed Web of Science ®Google Scholar
• Tanaka T, Furukawa T, Fujieda S, Kasamatsu S, Yonekura Y, Fujibayashi Y. Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models. Nuclear Medicine and Biology 2006; 33: 743–750
   PubMed Web of Science ®Google Scholar
• Thews O, Kelleher D, Vaupel P. Lack of association between tumor oxygenation and cell cycle distribution or proliferation kinetics in experimental sarcomas. Advances in Experimental Medicine and Biology 2003; 540: 245–250
   PubMed Web of Science ®Google Scholar
• Yaromina A, Zips D, Thames H D, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh J A, Quennet V, Walenta S, Mueller-Klieser W, Baumann M. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiotherapy and Oncology 2006; 81: 122–129
   PubMed Web of Science ®Google Scholar
• Zolzer F, Streffer C. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. International Journal of Radiation Oncology, Biology, Physics 2002; 54: 910–920
   PubMed Web of Science ®Google Scholar